Provided by Tiger Trade Technology Pte. Ltd.

ABVC BioPharma, Inc.

0.9700
-0.0900-8.49%
Pre-market: 1.060.0900+9.28%05:54 EDT
Volume:94.60K
Turnover:94.86K
Market Cap:25.85M
PE:-3.40
High:1.08
Open:1.08
Low:0.9500
Close:1.06
52wk High:3.40
52wk Low:0.7069
Shares:26.65M
Float Shares:21.83M
Volume Ratio:0.71
T/O Rate:0.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2855
EPS(LYR):-0.3933
ROE:-69.86%
ROA:-22.85%
PB:2.51
PE(LYR):-2.47

Loading ...

Cingulate Faces FDA Delay But Maintains ADHD Drug Plans

TIPRANKS
·
Jun 02

Cingulate Receives Complete Response Letter from FDA for CTx-1301

GlobeNewswire
·
Jun 02

Collegium Pharma Leans on ADHD to Drive Growth

TIPRANKS
·
May 20

ABVC BioPharma Q1 EPS $(0.06), Same YoY

Benzinga Earnings
·
May 18

ABVC Biopharma Q1 FY26 net loss widens 79% to $1.69 million

Reuters
·
May 18

ABVC BioPharma delays filing quarterly report for period ended March 31, 2026

Reuters
·
May 16

Press Release: Cingulate Inc. Reports First Quarter 2026 Financial Results and Provides an Update of Commercial Readiness Efforts On Track for lead ADHD Asset CTx-1301

Dow Jones
·
May 14

Collegium Pharmaceutical Completes AZSTARYS ADHD Business Acquisition

TIPRANKS
·
May 12

Press Release: Collegium Completes Acquisition of AZSTARYS(R) from Corium Therapeutics

Dow Jones
·
May 12

Yukiguni Maitake Sees FY Net Y2.54B

Dow Jones
·
May 11

Press Release: Collegium Reports First Quarter 2026 Financial Results and Highlights Recent Company Progress

Dow Jones
·
May 07

Regencell Bioscience Holdings Faces Federal Securities Lawsuit Over Alleged Market Manipulation Disclosures

TIPRANKS
·
May 07

Alto Neuroscience presents Phase 2a data for ALTO-207 in MDD

TIPRANKS
·
May 04

Regencell Bioscience Holdings Faces Investor Lawsuit Alleging Securities Fraud Tied to DOJ Investigation and Stock Volatility

TIPRANKS
·
May 02

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Apr 30

Humanwell Healthcare Subsidiary Gets China Nod for ADHD Treatment

MT Newswires Live
·
Apr 09

ABVC BioPharma Shareholders Back Board, Equity Plan Changes

TIPRANKS
·
Mar 28

ABVC Biopharma held annual shareholder meeting; quorum reached with 10.6 million shares represented by proxy

Reuters
·
Mar 28

Press Release: LB Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Dow Jones
·
Mar 27

BrainsWay Completes Additional $6 Million Milestone-Based Investment in Neurolief Ltd. Following FDA Approval of Proliv™Rx System for MDD

GlobeNewswire
·
Mar 26